Food, Drugs, Healthcare, Life Sciences

As previously indicated in our July 2025 bulletin, the Régie de l'assurance maladie du Québec ("RAMQ") has been implementing significant reforms to the Exceptional Patient Measure (in French, la mesure du patient d'exception, "PE Measure").

Does Mounjaro lead to stomach paralysis? What risks are associated with Xarelto blood thinner? Does Dupixent cause cancer?

The festive season is upon us, bringing with it annual traditions that reflect Ontario's diverse multicultural population. This is the time when people typically gather with family and friends...

On November 8, 2025, the Department of Health published proposed amendments to the Medical Devices Regulations, SOR/98-282 (MDR) with a specific...

Le 8 novembre 2025, Santé Canada a publié le Règlement modifiant le Règlement sur les instruments médicaux (licences d'établissement) (le « projet de règlement ») dans La Gazette du Canada...

Patent term adjustment (PTA) to compensate for unreasonable delays at the Canadian Intellectual Property Office (CIPO) may apply to Canadian patents granted...

On December 8, 2025, the Honorable Lena Metlege Diab, Minister of Immigration, Refugees and Citizenship, and Maggie Chi, Parliamentary Secretary to the Minister of Health, announced a new permanent residency pathway for international physicians that have the relevant Canadian work experience.

On November 3, 2025, Ontario enacted the Building a More Competitive Economy Act, 2025 ("Bill 56"), introducing significant updates to the province's health-regulatory framework.

Comme indiqué précédemment dans notre bulletin de juillet 2025 (en anglais seulement), la Régie de l'assurance maladie du Québec (« RAMQ ») a mis en œuvre des réformes importantes concernant la mesure du patient d'exception (ou « mesure PE »).